Skip to main content
. 2022 Dec 27;5(12):e2248332. doi: 10.1001/jamanetworkopen.2022.48332

Table 2. Associated Diagnoses and Symptoms in Patients in High-risk Group 1 and Patients in High-risk Group 2 Compared With Matched Controls.

Time and diagnosis Patients, No. (%) after matching OR (95% CI) P valueb Patients, No. (%) after matching OR (95% CI) P valueb
High-risk group 1 (n = 20 175)a Matched controls (n = 20 175) High-risk group 2 (n = 24 905)c Matched controls (n = 24 905)
0 to ≤1 y
Osteopenia or osteoporosis 2662 (13.2) 1099 (5.4) 2.64 (2.45-2.84) <.001 1423 (5.7) 1065 (4.3) 1.36 (1.25-1.47) <.001
Fractures 719 (3.6) 478 (2.4) 1.52 (1.35-1.71) <.001 691 (2.8) 603 (2.4) 1.15 (1.03-1.29) .01
Urolithiasis 771 (3.8) 281 (1.4) 2.81 (2.45-3.23) <.001 746 (3.0) 378 (1.5) 2.00 (1.77-2.27) <.001
MDD 2009 (10.0) 1393 (6.9) 1.49 (1.39-1.60) <.001 2507 (10.1) 1565 (6.3) 1.67 (1.56-1.78) <.001
Anxiety disorders 1920 (9.5) 1347 (6.7) 1.47 (1.37-1.58) <.001 2481 (10.0) 1689 (6.8) 1.52 (1.43-1.62) <.001
HTN 9107 (45.1) 6231 (30.9) 1.84 (1.77-1.92) <.001 8872 (35.6) 5795 (23.3) 1.83 (1.76-1.90) <.001
GERD 2952 (14.6) 2047 (10.1) 1.52 (1.43-1.61) <.001 3186 (12.8) 2241 (9.0) 1.48 (1.40-1.57) <.001
Malaise or fatigue 2065 (10.2) 1328 (6.6) 1.62 (1.51-1.74) <.001 2086 (8.4) 1455 (5.8) 1.47 (1.38-1.58) <.001
Joint pain or myalgias 3461 (17.2) 2385 (11.8) 1.55 (1.46-1.63) <.001 3745 (15.0) 2834 (11.4) 1.38 (1.31-1.45) <.001
Constipation 1247 (6.2) 719 (3.6) 1.78 (1.54-1.96) <.001 1334 (5.4) 687 (2.8) 2.00 (1.82-2.19) <.001
Insomnia 885 (4.4) 524 (2.6) 1.72 (1.54-1.92) <.001 937 (3.8) 570 (2.3) 1.67 (1.50-1.86) <.001
Polyuria 874 (4.3) 506 (2.5) 1.76 (1.58-1.97) <.001 905 (3.6) 607 (2.4) 1.51 (1.36-1.68) <.001
Weakness 1374 (6.8) 872 (4.3) 1.62 (1.48-1.77) <.001 1413 (5.7) 891 (3.6) 1.62 (1.49-1.77) <.001
Abdominal pain 2142 (10.6) 1573 (7.8) 1.41 (1.31-1.50) <.001 3067 (12.3) 1916 (7.7) 1.69 (1.59-1.79) <.001
Headache 1104 (5.5) 794 (3.9) 1.41 (1.29-1.55) <.001 1320 (5.3) 891 (3.6) 1.51 (1.38-1.65) <.001
Nausea 814 (4.0) 498 (2.5) 1.66 (1.48-1.86) <.001 1013 (4.1) 567 (2.3) 1.82 (1.64-2.02) <.001
Amnesia 738 (3.7) 506 (2.5) 1.48 (1.32-1.66) <.001 992 (4.0) 566 (2.3) 1.78 (1.61-1.98) <.001
Gallstones 373 (1.8) 217 (1.1) 1.73 (1.46-2.05) <.001 480 (1.9) 282 (1.1) 1.72 (1.48-1.98) <.001
366 d to ≤2 y
Osteopenia or osteoporosis 2718 (13.5) 1070 (5.3) 2.78 (2.58-2.99) <.001 1461 (5.9) 1002 (4.0) 1.49 (1.37-1.61) <.001
Fractures 647 (3.2) 367 (1.8) 1.79 (1.57-2.04) <.001 581 (2.3) 370 (1.5) 1.58 (1.39-1.81) <.001
Urolithiasis 651 (3.2) 198 (1.0) 3.36 (2.87-3.95) <.001 539 (2.2) 225 (0.9) 2.43 (2.08-2.84) <.001
MDD 1909 (9.5) 1164 (5.8) 1.71 (1.58-1.84) <.001 2088 (8.4) 1213 (4.9) 1.79 (1.66-1.92) <.001
Anxiety disorders 1740 (8.6) 1105 (5.5) 1.63 (1.51-1.76) <.001 2056 (8.3) 1379 (5.5) 1.54 (1.43-1.65) <.001
HTN 8940 (44.3) 5057 (25.1) 2.38 (2.28-2.48) <.001 7814 (31.4) 4327 (17.4) 2.17 (2.08-2.27) <.001
GERD 2690 (13.3) 1606 (8.0) 1.78 (1.67-1.90) <.001 2676 (10.7) 1643 (6.6) 1.70 (1.60-1.82) <.001
Malaise or fatigue 1531 (7.6) 898 (4.5) 1.76 (1.62-1.92) <.001 1487 (6.0) 958 (3.8) 1.59 (1.46-1.73) <.001
Joint pain or myalgias 3327 (16.5) 2004 (9.9) 1.79 (1.69-1.90) <.001 3167 (12.7) 2285 (9.2) 1.44 (1.36-1.53) <.001
Constipation 1001 (5.0) 472 (2.3) 2.18 (1.95-2.44) <.001 935 (3.8) 443 (1.8) 2.15 (1.92-2.42) <.001
Insomnia 725 (3.6) 395 (2.0) 1.86 (1.65-2.11) <.001 754 (3.0) 418 (1.7) 1.83 (1.62-2.06) <.001
Polyuria 786 (3.9) 420 (2.1) 1.91 (1.69-2.15) <.001 724 (2.9) 515 (2.1) 1.42 (1.27-1.59) <.001
Weakness 948 (4.7) 547 (2.8) 1.77 (1.59-1.97) <.001 949 (3.8) 548 (2.2) 1.76 (1.58-1.96) <.001
Abdominal pain 1698 (8.4) 949 (4.7) 1.86 (1.72-2.02) <.001 2020 (8.1) 1102 (4.4) 1.91 (1.77-2.06) <.001
Headache 923 (4.6) 505 (2.5) 1.87 (1.67-2.09) <.001 890 (3.6) 543 (2.2) 1.66 (1.49-1.85) <.001
Nausea 598 (3.0) 292 (1.4) 2.08 (1.81-2.40) <.001 614 (2.5) 277 (1.1) 2.25 (1.95-2.59) <.001
Amnesia 635 (3.1) 373 (1.8) 1.73 (1.52-1.96) <.001 683 (2.7) 336 (1.3) 2.06 (1.81-2.35) <.001
Gallstones 265 (1.3) 124 (0.6) 2.15 (1.74-2.67) <.001 264 (1.1) 107 (0.4) 2.48 (1.98-3.11) <.001
731 d to ≤3 y
Osteopenia or osteoporosis 2945 (14.6) 1254 (6.2) 2.58 (2.41-2.76) <.001 1635 (6.6) 1117 (4.5) 1.50 (1.38-1.62) <.001
Fractures 679 (3.4) 418 (2.1) 1.65 (1.46-1.86) <.001 616 (2.5) 424 (1.7) 1.46 (1.29-1.66) <.001
Urolithiasis 644 (3.2) 175 (0.9) 3.77 (3.19-4.46) <.001 549 (2.2) 230 (0.9) 2.42 (2.07-2.82) <.001
MDD 2024 (10.0) 1200 (5.9) 1.76 (1.64-1.90) <.001 2087 (8.4) 1247 (5.0) 1.74 (1.61-1.87) <.001
Anxiety disorders 1835 (9.1) 1163 (5.8) 1.64 (1.52-1.77) <.001 2175 (8.7) 1433 (5.8) 1.57 (1.46-1.68) <.001
HTN 9124 (45.2) 5346 (26.5) 2.29 (2.20-2.39) <.001 8121 (32.6) 4670 (18.8) 2.10 (2.01-2.19) <.001
GERD 2800 (13.9) 1760 (8.7) 1.69 (1.58-1.80) <.001 2801 (11.2) 1803 (7.2) 1.62 (1.53-1.73) <.001
Malaise or fatigue 1574 (7.8) 917 (4.5) 1.78 (1.63-1.93) <.001 1488 (6.0) 1028 (4.1) 1.48 (1.36-1.60) <.001
Joint pain or myalgias 3285 (16.3) 2082 (10.3) 1.69 (1.59-1.79) <.001 3246 (13.0) 2361 (9.5) 1.43 (1.35-1.51) <.001
Constipation 1017 (5.0) 511 (2.5) 2.04 (1.83-2.28) <.001 948 (3.8) 513 (2.1) 1.88 (1.69-2.10) <.001
Insomnia 774 (3.8) 436 (2.2) 1.81 (1.60-2.03) <.001 765 (3.1) 484 (1.9) 1.60 (1.43-1.79) <.001
Polyuria 849 (4.2) 511 (2.5) 1.69 (1.51-1.89) <.001 737 (3.0) 525 (2.1) 1.42 (1.26-1.59) <.001
Weakness 1034 (5.1) 577 (2.9) 1.84 (1.65-2.04) <.001 914 (3.7) 587 (2.4) 1.58 (1.42-1.75) <.001
Abdominal pain 1725 (8.6) 1041 (5.2) 1.72 (1.59-1.86) <.001 2056 (8.3) 1145 (4.6) 1.87 (1.73-2.01) <.001
Headache 848 (4.2) 480 (2.4) 1.80 (1.61-2.02) <.001 892 (3.6) 542 (2.2) 1.67 (1.50-1.86) <.001
Nausea 576 (2.9) 289 (1.3) 2.02 (1.75-2.33) <.001 575 (2.3) 303 (1.2) 1.92 (1.67-2.21) <.001
Amnesia 681 (3.4) 404 (2.0) 1.71 (1.51-1.94) <.001 737 (3.0) 379 (1.5) 1.97 (1.74-2.24) <.001
Gallstones 267 (1.3) 132 (0.7) 2.04 (1.65-2.51) <.001 296 (1.2) 144 (0.6) 2.07 (1.69-2.53) <.001
Entire study period (0-3 y)
Osteopenia or osteoporosis 4447 (22.0) 2221 (11.0) 2.29 (2.16-2.42) <.001 2758 (11.1) 2012 (8.1) 1.42 (1.33-1.51) <.001
Fractures 1450 (7.2) 1044 (5.2) 1.42 (1.31-1.54) <.001 1501 (6.0) 1166 (4.7) 1.31 (1.21-1.41) <.001
Urolithiasis 1262 (6.3) 470 (2.3) 2.80 (2.51-3.12) <.001 1315 (5.3) 637 (2.6) 2.12 (1.93-2.34) <.001
MDD 3218 (16.0) 2253 (11.2) 1.51 (1.43-1.60) <.001 3824 (15.4) 2491 (10.0) 1.63 (1.55-1.72) <.001
Anxiety disorders 3097 (15.4) 2177 (10.8) 1.50 (1.41-1.59) <.001 3889 (15.6) 2772 (11.1) 1.48 (1.40-1.56) <.001
HTN 11 187 (55.5) 8114 (40.2) 1.85 (1.78-1.93) <.001 11 436 (45.9) 7813 (31.4) 1.86 (1.79-1.93) <.001
GERD 4602 (22.8) 3430 (17.0) 1.44 (1.33-1.52) <.001 5035 (20.2) 3588 (14.4) 1.51 (1.44-1.58) <.001
Malaise or fatigue 3687 (18.3) 2428 (12.0) 1.63 (1.54-1.73) <.001 3812 (15.3) 2716 (10.9) 1.48 (1.40-1.56) <.001
Joint pain or myalgias 6266 (31.1) 4591 (22.8) 1.53 (1.46-1.60) <.001 6786 (27.2) 5395 (21.7) 1.35 (1.30-1.41) <.001
Constipation 2335 (11.6) 1316 (6.5) 1.88 (1.75-2.01) <.001 2447 (9.8) 1306 (5.2) 1.97 (1.84-2.12) <.001
Insomnia 1592 (7.9) 994 (4.9) 1.65 (1.52-1.79) <.001 1675 (6.7) 1034 (4.2) 1.67 (1.54-1.80) <.001
Polyuria 1905 (9.4) 1205 (6.0) 1.64 (1.52-1.77) <.001 1871 (7.5) 1319 (5.3) 1.45 (1.35-1.56) <.001
Weakness 2522 (12.5) 1670 (8.3) 1.58 (1.52-1.77) <.001 2639 (10.6) 1690 (6.8) 1.63 (1.53-1.74) <.001
Abdominal pain 3979 (19.7) 2844 (14.1) 1.50 (1.42-1.58) <.001 5188 (20.8) 3406 (13.7) 1.66 (1.58-1.74) <.001
Headache 2155 (10.7) 1453 (7.2) 1.54 (1.44-1.65) <.001 2462 (9.9) 1636 (6.6) 1.56 (1.46-1.67) <.001
Nausea 1518 (7.5) 919 (4.6) 1.71 (1.57-1.86) <.001 1795 (7.2) 1009 (4.1) 1.84 (1.70-1.99) <.001
Amnesia 1484 (7.4) 965 (4.8) 1.58 (1.45-1.72) <.001 1852 (7.4) 1005 (4.0) 1.91 (1.77-2.07) <.001
Gallstones 708 (3.5) 442 (2.2) 1.62 (1.44-1.83) <.001 866 (3.5) 475 (1.9) 1.85 (1.65-2.08) <.001

Abbreviations: GERD, gastroesophageal reflux disease; HTN, hypertension; MDD, major depressive disorder; OR, odds ratio.

a

High risk-group 1 included a total of 20 176 patients with hypercalcemia and parathyroid hormone greater than or equal to 50 pg/mL.

b

Statistical significance is defined as P < .003.

c

High-risk group 2 included 24 905 patients with unexplained hypercalcemia and no further workup.